Cargando…

Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis

BACKGROUND: Subjects of Chinese heritage have been found to participate in clinical research at lower rates than other groups despite growing in numbers as a population. While much research has examined research participants' motivation, there has not been a comprehensive synthesis of this info...

Descripción completa

Detalles Bibliográficos
Autores principales: Limkakeng, Alexander, Phadtare, Amruta, Shah, Jatin, Vaghasia, Meenakshi, Wei, Ding Ying, Shah, Anand, Pietrobon, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547937/
https://www.ncbi.nlm.nih.gov/pubmed/23349672
http://dx.doi.org/10.1371/journal.pone.0051328
_version_ 1782256260786159616
author Limkakeng, Alexander
Phadtare, Amruta
Shah, Jatin
Vaghasia, Meenakshi
Wei, Ding Ying
Shah, Anand
Pietrobon, Ricardo
author_facet Limkakeng, Alexander
Phadtare, Amruta
Shah, Jatin
Vaghasia, Meenakshi
Wei, Ding Ying
Shah, Anand
Pietrobon, Ricardo
author_sort Limkakeng, Alexander
collection PubMed
description BACKGROUND: Subjects of Chinese heritage have been found to participate in clinical research at lower rates than other groups despite growing in numbers as a population. While much research has examined research participants' motivation, there has not been a comprehensive synthesis of this information with respect to participants of Chinese descent. We sought to identify the factors that promote and hinder participation in clinical research among participants of Chinese heritage. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a systematic review of the literature in Pubmed, OpenJGATE, SCIRUS, and COCHRANE databases and performed a meta-synthesis of retrieved articles. We extracted qualitative data, such as quotes to identify emerging themes. We identified five studies that met our selection criteria. Of them, only one (1/5) was conducted in China while other studies involved Chinese emigrants in USA (3/5) and Singapore (1/5). Participants from China were similar to emigrants with regard to factors that either promoted or decreased research participation. Four studies reported data exclusively on Chinese subjects. Three of the five studies involved qualitative interviews while the others were conducted using a survey design. Six themes favoring research participation were identified: Personal Benefit to Participants, Financial Incentives, Participant Sense of Altruism, Family or Physician Recommendations, Advertisements, and Convenience to the Participant. Five factors were seen as a barrier to participation in clinical trials: Mistrust of Researchers, Language Barrier, Lack of Financial and Other Support, Cultural and Social Barriers, Lack of Knowledge about Clinical Trials. CONCLUSIONS/SIGNIFICANCE: Chinese heritage clinical research participants value personal benefit, financial incentives, the ability to help others, recommendations of others, advertisements, and convenience when considering clinical research participation. In addition, the establishment of trust and addressing knowledge deficits are important factors to them. Investigators seeking to optimize enrolment in these populations should incorporate these findings into their study design and subject handouts.
format Online
Article
Text
id pubmed-3547937
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35479372013-01-24 Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis Limkakeng, Alexander Phadtare, Amruta Shah, Jatin Vaghasia, Meenakshi Wei, Ding Ying Shah, Anand Pietrobon, Ricardo PLoS One Research Article BACKGROUND: Subjects of Chinese heritage have been found to participate in clinical research at lower rates than other groups despite growing in numbers as a population. While much research has examined research participants' motivation, there has not been a comprehensive synthesis of this information with respect to participants of Chinese descent. We sought to identify the factors that promote and hinder participation in clinical research among participants of Chinese heritage. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a systematic review of the literature in Pubmed, OpenJGATE, SCIRUS, and COCHRANE databases and performed a meta-synthesis of retrieved articles. We extracted qualitative data, such as quotes to identify emerging themes. We identified five studies that met our selection criteria. Of them, only one (1/5) was conducted in China while other studies involved Chinese emigrants in USA (3/5) and Singapore (1/5). Participants from China were similar to emigrants with regard to factors that either promoted or decreased research participation. Four studies reported data exclusively on Chinese subjects. Three of the five studies involved qualitative interviews while the others were conducted using a survey design. Six themes favoring research participation were identified: Personal Benefit to Participants, Financial Incentives, Participant Sense of Altruism, Family or Physician Recommendations, Advertisements, and Convenience to the Participant. Five factors were seen as a barrier to participation in clinical trials: Mistrust of Researchers, Language Barrier, Lack of Financial and Other Support, Cultural and Social Barriers, Lack of Knowledge about Clinical Trials. CONCLUSIONS/SIGNIFICANCE: Chinese heritage clinical research participants value personal benefit, financial incentives, the ability to help others, recommendations of others, advertisements, and convenience when considering clinical research participation. In addition, the establishment of trust and addressing knowledge deficits are important factors to them. Investigators seeking to optimize enrolment in these populations should incorporate these findings into their study design and subject handouts. Public Library of Science 2013-01-17 /pmc/articles/PMC3547937/ /pubmed/23349672 http://dx.doi.org/10.1371/journal.pone.0051328 Text en © 2013 Limkakeng et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Limkakeng, Alexander
Phadtare, Amruta
Shah, Jatin
Vaghasia, Meenakshi
Wei, Ding Ying
Shah, Anand
Pietrobon, Ricardo
Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis
title Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis
title_full Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis
title_fullStr Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis
title_full_unstemmed Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis
title_short Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis
title_sort willingness to participate in clinical trials among patients of chinese heritage: a meta-synthesis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547937/
https://www.ncbi.nlm.nih.gov/pubmed/23349672
http://dx.doi.org/10.1371/journal.pone.0051328
work_keys_str_mv AT limkakengalexander willingnesstoparticipateinclinicaltrialsamongpatientsofchineseheritageametasynthesis
AT phadtareamruta willingnesstoparticipateinclinicaltrialsamongpatientsofchineseheritageametasynthesis
AT shahjatin willingnesstoparticipateinclinicaltrialsamongpatientsofchineseheritageametasynthesis
AT vaghasiameenakshi willingnesstoparticipateinclinicaltrialsamongpatientsofchineseheritageametasynthesis
AT weidingying willingnesstoparticipateinclinicaltrialsamongpatientsofchineseheritageametasynthesis
AT shahanand willingnesstoparticipateinclinicaltrialsamongpatientsofchineseheritageametasynthesis
AT pietrobonricardo willingnesstoparticipateinclinicaltrialsamongpatientsofchineseheritageametasynthesis